Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC084219.2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | H1FX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ARHGEF12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | MYO7A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | EPN1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | IGFL4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | CYP2U1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | SIAH1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |